butorphanol has been researched along with Canine Hip Dysplasia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Granholm, MM; Leppänen, MK; McKusick, BC; Short, CE; Tulamo, R; Westerholm, FC | 1 |
Audell, L; Danell, B; Hedhammar, A; Malm, S; Strandberg, E; Swenson, L | 1 |
1 trial(s) available for butorphanol and Canine Hip Dysplasia
Article | Year |
---|---|
Clinical efficacy and safety of dexmedetomidine and buprenorphine, butorphanol or diazepam for canine hip radiography.
Topics: Animals; Buprenorphine; Butorphanol; Conscious Sedation; Dexmedetomidine; Diazepam; Dogs; Drug Therapy, Combination; Female; Hip Dysplasia, Canine; Hypnotics and Sedatives; Infusions, Intravenous; Injections, Intramuscular; Male; Pedigree; Radiography; Treatment Outcome | 2006 |
1 other study(ies) available for butorphanol and Canine Hip Dysplasia
Article | Year |
---|---|
Impact of sedation method on the diagnosis of hip and elbow dysplasia in Swedish dogs.
Topics: Acepromazine; Age Factors; Animals; Butorphanol; Conscious Sedation; Diagnosis, Differential; Dogs; Female; Genetic Predisposition to Disease; Hip Dysplasia, Canine; Hypnotics and Sedatives; Logistic Models; Male; Mass Screening; Medetomidine; Odds Ratio; Pedigree; Predictive Value of Tests; Sex Factors; Surveys and Questionnaires; Sweden; Xylazine | 2007 |